The Professional Research Subject Problem In Clinical Trials

Clinical research patients are compensated for their participation in clinical trials. In some therapeutic areas and types of clinical trials, the compensation for enrolling in one or more clinical trials or at multiple research sites is enough to influence patients to join more than one contemporaneously and expose themselves to multiple investigational products or multiple …

Read more

RESEARCH SITES AND SPONSORS COOPERATE TO PREVENT PROFESSIONAL RESEARCH SUBJECTS IN CNS CLINICAL TRIALS BY USING VERIFIED CLINICAL TRIALS

Duplicate subjects, or what is known as professional research subjects, exist in most clinical trials to varying degrees. CNS clinical trials are especially prone to duplicate subjects or over enrollment in clinical tials. The issue exists from phase 1 healthy volunteer studies to multiple phase 2/3 clinical trials across many therapeutic indications. Use of global …

Read more

Screen Shot 2020 06 24 at 9.32.25 PM

Prevent Professional Research Subjects With Verified Clinical Trials

Professional research subjects cause issues with placebo rates, data quality and safety.  The issue is more common than most would think.  Upwards of 10% of research subjects will attempt to enroll in more than one clinical trial concurrently or before a safe and mandatory wash out period has occurred. Without a tool like Verified Clinical …

Read more

Screen Shot 2019 05 30 at 12.33.36 PM

Understanding Research Subjects Behaviors & Travel Habits: Duplicate Subjects In CNS Clinical Trials

Verified Clinical Trials (VCT) presented a poster at the ASCP meeting in Phoenix May 2019, detailing travel habits and distances specifically in CNS clinical trials. Bottom line: In many instances, research subjects travel large distances to become duplicate subjects in CNS clinical trials. A research subject database is needed to prevent duplicate subjects and many …

Read more

Screen Shot 2018 06 27 at 11.15.03 PM

No Specific Characteristics Of A Duplicate Subject And A Research Subject Database Is Required

Without a “tool” such as the Verified Clinical Trials (VCT) global research subjects database registry, detecting duplicate subjects and protocol violations based upon prior study history or prior study drug (IP) exposure is impossible. VCT proactively detects these issues at the time of screening before costly screening procedures occur. The protections continue the entire duration …

Read more

Screen Shot 2018 04 19 at 3.41.36 PM

Duplicate Subjects In CNS Clinical Trials and Other Therapeutic Areas Prevented With Verified Clinical Trials Research Subject Database Registry

From phase 1 through phase 4 drug development, the issue of duplicate subjects in clinical trials exists.  Verified Clinical Trials (VCT). www.verifiedclinicaltrials.com is here to prevent these issues and promote safety and data quality.  Duplicate subjects in CNS clinical trials is especially needed, but VCT protects most therapeutic areas. Characteristics of duplicate subjects are not …

Read more

Screen Shot 2019 04 23 at 4.01.09 PM

Research Sites Cooperate To Prevent Duplicate Subjects in CNS Clinical Trials By Using The Verified Clinical Trials Research Subject Registry

Duplicate subjects exist in most clinical trials to varying degrees.  CNS clinical trials are especially  prone to duplicate subject or over enrollment.  The issue exists from phase 1 healthy volunteer studies to multiple phase 2/3 clinical trials across many therapeutic indications.  Use of global research subject database registry such as Verified Clinical Trials will help …

Read more

Screenshot 2017 06 03 09.56.26 1

Duplicate Subjects In Clinical Trials Can Be Prevented With A Global Research Subject Registry

Duplicate subjects in clinical trials is unfortunately a common issue that affects all trials from most every indication and across all phases of clinical trials research.  These professional research subjects can be prevented by using Verified Clinical Trials (VCT) the global research subject registry.  Nearly all of the phase 1 units across the United States …

Read more

Screen Shot 2019 01 28 at 1.26.06 PM

Duplicate subjects can be prevented with Verified Clinical Trials

Duplicate subjects and preventable protocol violations can easily be prevented up-front at the time of screening using the global research subject database registry Verified Clinical Trials (VCT). The protections continue for the entire duration fo the study including the specific washout criteria.  VCT has data that routinely demonstrates double digit preventable protocol violations. Professional research …

Read more

Research Centers of America Adopts Verified Clinical Trials Biometrics Research Subject Database Registry to Prevent Duplicate Enrollment in Clinical Trial

  Verified Clinical Trials & Research Centers of America partner to stop duplicate enrollment in South Florida We are grateful for this innovative resource and the real-time responses that have helped us avoid duplicate enrollment in our clinical trials. We are truly impressed with the staff at VCT and their readin.ess to help at every …

Read more